Senior insider sale
Chief Scientific Officer at EVOMMUNE, INC. — senior position signals high conviction
$422.2K
18.18K shares
What this filing means
PATEL JEEGAR PRAVINKUMAR plans to sell 18.18K shares of EVOMMUNE, INC. valued at approximately $422.2K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/1/2026ACC: 0001950047-26-005430
Officer· Chief Scientific Officer
Since Nov 2025
18.18K
Shares to sell
$422.2K
Approx. market value
18.18K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months2
Exercise of Stock Options
Cash
6/1/2026
15KPre-IPO Purchase of Common Shares
Cash
4/26/2023
3.17KTotal acquired18.18K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/1/2026 | Exercise of Stock Options Cash | 15K | — |
4/26/2023 | Pre-IPO Purchase of Common Shares Cash | 3.17K | — |
| Total | 18.18K | ||
Planned & Completed Dispositions1
NYSEPlanned
Units to sell
18.18K
Market value
$422.2K
6/1/2026
Total
Units
18.18K
Value
$422.2K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
6/1/2026 | 18.18K | $422.2K | NYSE | Planned |
| Total | 18.18K | $422.2K | ||